{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:56:56Z","timestamp":1777424216817,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T00:00:00Z","timestamp":1482451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T00:00:00Z","timestamp":1482451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Farnesyl pyrophosphate synthase (FPPS) is a key enzyme in the mevalonate pathway. In our previous studies, we find that inhibition of FPPS attenuates angiotensin II-induced cardiac hypertrophy and fibrosis by suppressing RhoA while FPPS and Ras are up-regulated in pressure overload rats. In this study, we evaluate the effects and mechanisms of FPPS inhibition in pressure overload mice. Male FPPS-small interfering RNA (SiRNA) transgenic (Tg) mice and non-transgenic littermate control (NLC) were randomly divided into suprarenal abdominal aortic constriction (AAC) group and sham operation group. 12 weeks following AAC, mice were sacrificed by cervical dislocation. Histological and echocardiographic assessments showed that inhibition of FPPS improved chronic cardiac remodeling which was induced by AAC. The reductions of Ras farnesylation and GTP-Ras, as well as their downstream extracellular signal-related kinases 1\/2 (ERK1\/2) expression were observed in the heart of Tg-AAC mice compared with NLC-AAC mice, along with the reduction of fetal gene expression. We provide here important experimental evidence that inhibition of FPPS improves AAC induced chronic cardiac remodeling and fibrosis by the reduction of farnesylated Ras and the downregulation of Ras-ERK1\/2 pathway.<\/jats:p>","DOI":"10.1038\/srep39186","type":"journal-article","created":{"date-parts":[[2016,12,24]],"date-time":"2016-12-24T21:27:25Z","timestamp":1482614845000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Inhibition of farnesyl pyrophosphate synthase improves pressure overload induced chronic cardiac remodeling"],"prefix":"10.1038","volume":"6","author":[{"given":"Chen-Ze","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Mou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Dong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Pu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen-Jiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,23]]},"reference":[{"key":"BFsrep39186_CR1","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1161\/CIRCULATIONAHA.104.500546","volume":"111","author":"DL Mann","year":"2005","unstructured":"Mann, D. L. & Bristow, M. R. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111, 2837\u20132849 (2005).","journal-title":"Circulation"},{"key":"BFsrep39186_CR2","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1056\/NEJM199910213411706","volume":"341","author":"JJ Hunter","year":"1999","unstructured":"Hunter, J. J. & Chien, K. R. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 341, 1276\u20131283 (1999).","journal-title":"N Engl J Med"},{"key":"BFsrep39186_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10741-012-9365-4","volume":"19","author":"AM Segura","year":"2014","unstructured":"Segura, A. M., Frazier, O. H. & Buja, L. M. Fibrosis and heart failure. Heart Fail Rev 19, 173\u2013185 (2014).","journal-title":"Heart Fail Rev"},{"key":"BFsrep39186_CR4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1073\/pnas.93.2.945","volume":"93","author":"J Ericsson","year":"1996","unstructured":"Ericsson, J., Jackson, S. M., Lee, B. C. & Edwards, P. A. Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene. Proc Natl Acad Sci USA 93, 945\u2013950 (1996).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep39186_CR5","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","volume":"26","author":"AS Dhillon","year":"2007","unstructured":"Dhillon, A. S., Hagan, S., Rath, O. & Kolch, W. MAP kinase signalling pathways in cancer. Oncogene 26, 3279\u20133290 (2007).","journal-title":"Oncogene"},{"key":"BFsrep39186_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1152\/physrev.2001.81.1.153","volume":"81","author":"Y Takai","year":"2001","unstructured":"Takai, Y., Sasaki, T. & Matozaki, T. Small GTP-binding proteins. Physiol Rev 81, 153\u2013208 (2001).","journal-title":"Physiol Rev"},{"key":"BFsrep39186_CR7","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1016\/j.bbamcr.2015.08.006","volume":"1853","author":"M Ramos-Kuri","year":"2015","unstructured":"Ramos-Kuri, M. et al. Dominant negative Ras attenuates pathological ventricular remodeling in pressure overload cardiac hypertrophy. Biochim Biophys Acta 1853, 2870\u20132884 (2015).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep39186_CR8","doi-asserted-by":"publisher","first-page":"21730","DOI":"10.1074\/jbc.273.34.21730","volume":"273","author":"PD Ho","year":"1998","unstructured":"Ho, P. D. et al. The Raf-MEK-ERK cascade represents a common pathway for alteration of intracellular calcium by Ras and protein kinase C in cardiac myocytes. J Biol Chem 273, 21730\u201321735 (1998).","journal-title":"J Biol Chem"},{"key":"BFsrep39186_CR9","first-page":"109","volume":"61","author":"BR Wei","year":"2011","unstructured":"Wei, B. R. et al. Capacity for resolution of Ras-MAPK-initiated early pathogenic myocardial hypertrophy modeled in mice. Comp Med 61, 109\u2013118 (2011).","journal-title":"Comp Med"},{"key":"BFsrep39186_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.biocel.2012.12.016","volume":"45","author":"J Yang","year":"2013","unstructured":"Yang, J. et al. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo. Int J Biochem Cell Biol 45, 657\u2013666 (2013).","journal-title":"Int J Biochem Cell Biol"},{"key":"BFsrep39186_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/cvr\/cvs347","volume":"97","author":"J Yang","year":"2013","unstructured":"Yang, J. et al. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice. Cardiovasc Res 97, 490\u2013499 (2013).","journal-title":"Cardiovasc Res"},{"key":"BFsrep39186_CR12","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1159\/000356610","volume":"32","author":"B Chen","year":"2013","unstructured":"Chen, B. et al. Alteration of mevalonate pathway related enzyme expressions in pressure overload-induced cardiac hypertrophy and associated heart failure with preserved ejection fraction. Cell Physiol Biochem 32, 1761\u20131775 (2013).","journal-title":"Cell Physiol Biochem"},{"key":"BFsrep39186_CR13","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1016\/j.ijcard.2013.04.038","volume":"168","author":"X Li","year":"2013","unstructured":"Li, X., Han, J., Li, L., Wang, K. J. & Hu, S. J. Effect of farnesyltransferase inhibition on cardiac remodeling in spontaneously hypertensive rats. Int J Cardiol 168, 3340\u20133347 (2013).","journal-title":"Int J Cardiol"},{"key":"BFsrep39186_CR14","first-page":"914026","volume":"2015","author":"J Yang","year":"2015","unstructured":"Yang, J. et al. Lentiviral-mediated silencing of farnesyl pyrophosphate synthase through RNA interference in mice. Biomed Res Int 2015, 914026 (2015).","journal-title":"Biomed Res Int"},{"key":"BFsrep39186_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.yjmcc.2014.10.005","volume":"77","author":"K Haghighi","year":"2014","unstructured":"Haghighi, K., Bidwell, P. & Kranias, E. G. Phospholamban interactome in cardiac contractility and survival, A new vision of an old friend. J Mol Cell Cardiol 77, 160\u2013167 (2014).","journal-title":"J Mol Cell Cardiol"},{"key":"BFsrep39186_CR16","doi-asserted-by":"publisher","first-page":"20968","DOI":"10.1074\/jbc.M703516200","volume":"282","author":"Z Chen","year":"2007","unstructured":"Chen, Z., Akin, B. L. & Jones, L. R. Mechanism of reversal of phospholamban inhibition of the cardiac Ca2+-ATPase by protein kinase A and by anti-phospholamban monoclonal antibody 2D12. J Biol Chem 282, 20968\u201320976 (2007).","journal-title":"J Biol Chem"},{"key":"BFsrep39186_CR17","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1161\/ATVBAHA.111.240754","volume":"32","author":"S Nagashima","year":"2012","unstructured":"Nagashima, S. et al. Liver-specific deletion of 3-hydroxy-3-methylglutaryl coenzyme A reductase causes hepatic steatosis and death. Arterioscler Thromb Vasc Biol 32, 1824\u20131831 (2012).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFsrep39186_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1194\/jlr.M021220","volume":"53","author":"SH Yang","year":"2012","unstructured":"Yang, S. H. et al. Severe hepatocellular disease in mice lacking one or both CaaX prenyltransferases. J Lipid Res 53, 77\u201386 (2012).","journal-title":"J Lipid Res"},{"key":"BFsrep39186_CR19","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/path.4480","volume":"235","author":"N Xu","year":"2015","unstructured":"Xu, N. et al. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure. J Pathol 235, 672\u2013685 (2015).","journal-title":"J Pathol"},{"key":"BFsrep39186_CR20","doi-asserted-by":"publisher","first-page":"38073","DOI":"10.1074\/jbc.M004804200","volume":"275","author":"Y Ji","year":"2000","unstructured":"Ji, Y. et al. Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte function. J Biol Chem 275, 38073\u201338080 (2000).","journal-title":"J Biol Chem"},{"key":"BFsrep39186_CR21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1161\/CIRCULATIONAHA.114.010686","volume":"131","author":"M Bisserier","year":"2015","unstructured":"Bisserier, M. et al. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+\/calmodulin-dependent protein kinase II signaling. Circulation 131, 390\u2013400, discussion 400 (2015).","journal-title":"Circulation"},{"key":"BFsrep39186_CR22","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.111.259754","volume":"110","author":"EG Kranias","year":"2012","unstructured":"Kranias, E. G. & Hajjar, R. J. Modulation of cardiac contractility by the phospholamban\/SERCA2a regulatome. Circ Res 110, 1646\u20131660 (2012).","journal-title":"Circ Res"},{"key":"BFsrep39186_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1748-1716.2012.02420.x","volume":"205","author":"Z Miklos","year":"2012","unstructured":"Miklos, Z. et al. Early cardiac dysfunction is rescued by upregulation of SERCA2a pump activity in a rat model of metabolic syndrome. Acta Physiol (Oxf) 205, 381\u2013393 (2012).","journal-title":"Acta Physiol (Oxf)"},{"key":"BFsrep39186_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00395-015-0514-5","volume":"110","author":"D Moreira-Goncalves","year":"2015","unstructured":"Moreira-Goncalves, D. et al. Cardioprotective effects of early and late aerobic exercise training in experimental pulmonary arterial hypertension. Basic Res Cardiol 110, 57 (2015).","journal-title":"Basic Res Cardiol"},{"key":"BFsrep39186_CR25","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/cvr\/cvr103","volume":"91","author":"M Sbroggio","year":"2011","unstructured":"Sbroggio, M. et al. IQGAP1 regulates ERK1\/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload. Cardiovasc Res 91, 456\u2013464 (2011).","journal-title":"Cardiovasc Res"},{"key":"BFsrep39186_CR26","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/CIRCRESAHA.109.201509","volume":"105","author":"J Xu","year":"2009","unstructured":"Xu, J. et al. Cardiomyocyte-specific loss of neurofibromin promotes cardiac hypertrophy and dysfunction. Circ Res 105, 304\u2013311 (2009).","journal-title":"Circ Res"},{"key":"BFsrep39186_CR27","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/ki.2009.498","volume":"77","author":"MT Grande","year":"2010","unstructured":"Grande, M. T. et al. Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice. Kidney Int 77, 509\u2013518 (2010).","journal-title":"Kidney Int"},{"key":"BFsrep39186_CR28","doi-asserted-by":"publisher","first-page":"H844","DOI":"10.1152\/ajpheart.00933.2013","volume":"306","author":"S Pramod","year":"2014","unstructured":"Pramod, S. & Shivakumar, K. Mechanisms in cardiac fibroblast growth, an obligate role for Skp2 and FOXO3a in ERK1\/2 MAPK-dependent regulation of p27kip1. Am J Physiol Heart Circ Physiol 306, H844\u2013855 (2014).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFsrep39186_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/cvr\/cvr067","volume":"91","author":"L Li","year":"2011","unstructured":"Li, L. et al. Angiotensin II increases periostin expression via Ras\/p38 MAPK\/CREB and ERK1\/2\/TGF-beta1 pathways in cardiac fibroblasts. Cardiovasc Res 91, 80\u201389 (2011).","journal-title":"Cardiovasc Res"},{"key":"BFsrep39186_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev.cb.10.110194.000335","volume":"10","author":"A Hall","year":"1994","unstructured":"Hall, A. Small GTP-binding proteins and the regulation of the actin cytoskeleton. Annu Rev Cell Biol 10, 31\u201354 (1994)","journal-title":"Annu Rev Cell Biol"},{"key":"BFsrep39186_CR31","doi-asserted-by":"publisher","first-page":"H66","DOI":"10.1152\/ajpheart.00724.2011","volume":"303","author":"TG von Lueder","year":"2012","unstructured":"von Lueder, T. G. et al. Cardiomyocyte-restricted inhibition of G protein-coupled receptor kinase-3 attenuates cardiac dysfunction after chronic pressure overload. Am J Physiol Heart Circ Physiol 303, H66\u201374 (2012).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFsrep39186_CR32","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1161\/ATVBAHA.107.140673","volume":"27","author":"M Sugita","year":"2007","unstructured":"Sugita, M., Sugita, H. & Kaneki, M. Farnesyltransferase inhibitor, manumycin a, prevents atherosclerosis development and reduces oxidative stress in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 27, 1390\u20131395 (2007).","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep39186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep39186","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep39186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:00:04Z","timestamp":1672887604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep39186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,23]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep39186"],"URL":"https:\/\/doi.org\/10.1038\/srep39186","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,23]]},"assertion":[{"value":"17 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39186"}}